Close Menu

Everyone rants about peer review, but what isn't very well known is that the process serves two purposes, says Chris Lee at Ars Technica. It both decides the value of research — something Lee says it does very well — and serves as "a gatekeeper for scientific funding" — which, Lee says, it doesn't do as well. In the first case, the great benefit to peer review is that it examines a researcher's methods well, Lee says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.